.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Colorcon
Chubb
Deloitte
Queensland Health
Novartis
Daiichi Sankyo
McKinsey
Fish and Richardson
UBS

Generated: June 28, 2017

DrugPatentWatch Database Preview

Sodium iodide i-131 - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium iodide i-131 and what is the scope of sodium iodide i-131 freedom to operate?

Sodium iodide i-131
is the generic ingredient in three branded drugs marketed by Jubilant Draximage, Mallinkrodt Nuclear, CIS, and Bracco, and is included in six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are one thousand three hundred and seventy-nine drug master file entries for sodium iodide i-131. Three suppliers are listed for this compound.

Summary for Generic Name: sodium iodide i-131

Tradenames:3
Patents:1
Applicants:4
NDAs:6
Drug Master File Entries: see list1379
Suppliers / Packagers: see list3
Clinical Trials: see list2,525
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sodium iodide i-131 at DailyMed

Pharmacology for Ingredient: sodium iodide i-131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cis
SODIUM IODIDE I 131
sodium iodide i-131
SOLUTION;ORAL017315-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Jubilant Draximage
HICON
sodium iodide i-131
SOLUTION;ORAL021305-002Jan 24, 2003DISCNNoNo► Subscribe► Subscribe
Jubilant Draximage
HICON
sodium iodide i-131
SOLUTION;ORAL021305-003Jan 24, 2003DISCNNoNo► Subscribe► Subscribe
Jubilant Draximage
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL021305-004Nov 18, 2004DISCNNoNo► Subscribe► Subscribe
Mallinkrodt Nuclear
SODIUM IODIDE I 131
sodium iodide i-131
CAPSULE;ORAL016515-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Novartis
US Army
Farmers Insurance
Johnson and Johnson
AstraZeneca
UBS
Healthtrust
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot